SCAFCINCY
  • Home
    • Sickle Cell Disease (SCD)
    • Related SCD Resources
  • Events
    • 5K Walk/Run
  • Sickle Cell News
    • Patient Spotlights
  • Programs
    • Patient Portal
    • Community Outreach
  • About Us
    • Executive Team
  • Donate
    • Our Partners
  • Contact Us
  • Home
    • Sickle Cell Disease (SCD)
    • Related SCD Resources
  • Events
    • 5K Walk/Run
  • Sickle Cell News
    • Patient Spotlights
  • Programs
    • Patient Portal
    • Community Outreach
  • About Us
    • Executive Team
  • Donate
    • Our Partners
  • Contact Us

Sickle Cell



​Related News

INSPIRING HOPE FOR PATIENTS AND FAMILIES LIVING
WITH SICKLE CELL

FDA Approves Oxbryta, the First Medicine Specifically Targeting The Root Cause of Sickle Cell Disease

12/4/2019

 
Picture
U.S. Food and Drug Administration approved Oxbryta, an oral therapy taken once daily, is the first approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of SCD.
Source: Healthline

Read More

Comments are closed.

    Scaf Cincy

    Sickle Cell Alliance Foundation is a non-profit organization based out of Cincinnati, Ohio.

    Archives

    September 2021
    July 2021
    June 2021
    March 2021
    February 2021
    December 2020
    October 2020
    May 2020
    April 2020
    January 2020
    December 2019
    November 2019
    August 2019
    July 2019
    June 2019

    Categories

    All
    Local News
    National News

SCAF Cincy

Home
About Us
Executive Team

Patient Resources

Sickle Cell Resources
Sickle Cell News
​Patient Portal

Support SCAF

Events
Donate Today
​Contact Us
© COPYRIGHT 2015-2023. ALL RIGHTS RESERVED.